| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |